|
|||||
|
|
Degree of MDM2 Amplification Affects Clinical Outcomes in Dedifferentiated Liposarcoma |
|
| Authors: | Kate Lynn J. Bill Nathan D. Seligson John L. Hays Achal Awasthi Bryce Demoret Colin W. Stets Megan C. Duggan Manojkumar Bupathi Guy N. Brock Sherri Z. Millis Reena Shakya Cynthia D. Timmers Paul E. Wakely Jr. Raphael E. Pollock James L. Chen |
| Affiliation: | 1. Division of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, Ohio, USA Wexner Medical Center and Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA Contributed equally.;2. Wexner Medical Center and Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA Contributed equally.;3. Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University, Columbus, Ohio, USA;4. Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA;5. Department of Biomedical Informatics, The Ohio State University, Columbus, Ohio, USA;6. Wexner Medical Center and Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA;7. Foundation Medicine Inc., Cambridge, Massachusetts, USA;8. Department of Pathology, The Ohio State University, Columbus, Ohio, USA;9. Division of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, Ohio, USA |
| Abstract: | |
| Keywords: | Dedifferentiated liposarcomas MDM2 Doxorubicin p53 Biomarker |